NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,022 Cr | ₹973 Cr | ₹891 Cr | ₹1,004 Cr | ₹1,187 Cr |
What is the latest Total Current Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹973 Cr |
| Mar2023 | ₹891 Cr |
| Mar2022 | ₹1,004 Cr |
| Mar2021 | ₹1,187 Cr |
How is Total Current Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 5.01 | |
| Mar2024 | ₹973 Cr | 9.19 | |
| Mar2023 | ₹891 Cr | -11.25 | |
| Mar2022 | ₹1,004 Cr | -15.46 | |
| Mar2021 | ₹1,187 Cr | - | |
Compare Total Current Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹269.1 Cr | -0.3% | -31.2% | -64.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.3% |
-31.2% |
-64.4% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses